Serum ghrelin is inversely associated with risk of subsequent oesophageal squamous cell carcinoma

Gut

Volumn 61, Issue 11, 2012, Pages 1533-1537

  Murphy, Gwen ^a   Kamangar, Farin ^b   Albanes, Demetrius ^a   Stanczyk, Frank Z ^c   Weinstein, Stephanie J ^a   Taylor, Philip R ^a   Virtamo, Jarmo ^d   Abnet, Christian C ^a   Dawsey, Sanford M ^a   Freedman, Neal D ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b MORGAN STATE UNIVERSITY   (United States)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^d NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; BETA CAROTENE; GHRELIN; PEPSINOGEN I; PEPSINOGEN II;

ADULT; AGE; ARTICLE; BLOOD SAMPLING; CANCER PATIENT; CANCER RISK; CASE CONTROL STUDY; CONTROLLED STUDY; DIET SUPPLEMENTATION; DISEASE ASSOCIATION; ENZYME ACTIVITY; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; FINLAND; HELICOBACTER INFECTION; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RISK ASSESSMENT;

CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; CONFIDENCE INTERVALS; ESOPHAGEAL NEOPLASMS; FEMALE; GHRELIN; HUMANS; INCIDENCE; MALE; MIDDLE AGED; ODDS RATIO; RADIOIMMUNOASSAY; REFERENCE VALUES; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; TUMOR MARKERS, BIOLOGICAL;

EID: 84866979889     PISSN: 00175749     EISSN: 14683288     Source Type: Journal    
DOI: 10.1136/gutjnl-2011-300653     Document Type: Article

References (39)

1. Ferlay J, Shin HR, Bray F, et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 2010;127:2893-917.
2. Kamangar F, Chow WH, Abnet CC, et al. Environmental causes of esophageal cancer. Gastroenterol Clin North Am 2009;38:27-57, vii.
3. Freedman ND, Abnet CC, Leitzmann MF, et al. A prospective study of tobacco, alcohol, and the risk of esophageal and gastric cancer subtypes. Am J Epidemiol 2007;165:1424-33. (Pubitemid 47234314)
4. Enzinger PC, Mayer RJ. Esophageal cancer. N Engl J Med 2003;349:2241-52. (Pubitemid 37485141)
5. Islami F, Kamangar F, Aghcheli K, et al. Epidemiologic features of upper gastrointestinal tract cancers in Northeastern Iran. Br J Cancer 2004;90:1402-6. (Pubitemid 38586269)
6. Higgins SC, Gueorguiev M, Korbonits M. Ghrelin, the peripheral hunger hormone. Ann Med 2007;39:116-36. (Pubitemid 46598179)
7. Cook MB, Dawsey SM, Diaw L, et al. Serum pepsinogens and Helicobacter pylori in relation to the risk of esophageal squamous cell carcinoma in the alpha-tocopherol, beta-carotene cancer prevention study. Cancer Epidemiol Biomarkers Prev 2010;19:1966-75.
8. Checchi S, Montanaro A, Pasqui L, et al. Serum ghrelin as a marker of atrophic body gastritis in patients with parietal cell antibodies. J Clin Endocrinol Metab 2007;92:4346-51. (Pubitemid 350074755)
9. de Martel C, Haggerty TD, Corley DA, et al. Serum ghrelin levels and risk of subsequent adenocarcinoma of the esophagus. Am J Gastroenterol 2007;102:1166-72. (Pubitemid 46801999)
10. Murphy G, Kamangar F, Dawsey SM, et al. The relationship between serum ghrelin and the risk of gastric and esophagogastric junctional adenocarcinomas. J Natl Cancer Inst 2011;103:1123-9.
11. The ATBC cancer prevention study group. The alpha-tocopherol, beta-carotene lung cancer prevention study: Design, methods, participant characteristics, and compliance. Ann Epidemiol 1994;4:1-10.
12. World Health Organization. International Statistical Classification of Diseases and Related Health Problems. Geneva, Switzerland: World Health Organization, 1978.
13. Percy C, Van Holten V, Muir CS. International Classification of Diseases for Oncology: ICD-O. Geneva: World Health Organization, 1990.
14. Pietinen P, Hartman AM, Haapa E, et al. Reproducibility and validity of dietary assessment instruments. I. A self-administered food use questionnaire with a portion size picture booklet. Am J Epidemiol 1988;128:655-66.
15. Kamangar F, Dawsey SM, Blaser MJ, et al. Opposing risks of gastric cardia and noncardia gastric adenocarcinomas associated with Helicobacter pylori seropositivity. J Natl Cancer Inst 2006;98:1445-52. (Pubitemid 44605589)
16. Kamangar F, Qiao YL, Blaser MJ, et al. Helicobacter pylori and oesophageal and gastric cancers in a prospective study in China. Br J Cancer 2007;96:172-6. (Pubitemid 46094658)
17. Iijima K, Koike T, Abe Y, et al. Extensive gastric atrophy: an increased risk factor for superficial esophageal squamous cell carcinoma in Japan. Am J Gastroenterol 2007;102:1603-9. (Pubitemid 47206685)
18. Islami F, Sheikhattari P, Ren JS, et al. Gastric atrophy and risk of oesophageal cancer and gastric cardia adenocarcinoma - a systematic review and meta-analysis. Ann Oncol 2011;22:754-60.
19. Kamangar F, Diaw L, Wei WQ, et al. Serum pepsinogens and risk of esophageal squamous dysplasia. Int J Cancer 2009;124:456-60.
20. Wu Y, Chen J, Ohshima H, et al. Geographic association between urinary excretion of N-nitroso compounds and oesophageal cancer mortality in China. Int J Cancer 1993;54:713-19. (Pubitemid 23228599)
21. Houben GM, Stockbrugger RW. Bacteria in the aetio-pathogenesis of gastric cancer: a review. Scand J Gastroenterol Suppl 1995;212:13-18.
22. de Vries AC, Capelle LG, Looman CW, et al. Increased risk of esophageal squamous cell carcinoma in patients with gastric atrophy: independent of the severity of atrophic changes. Int J Cancer 2009;124:2135-8.
23. Date Y, Kojima M, Hosoda H, et al. Ghrelin, a novel growth hormone-releasing acylated peptide, is synthesized in a distinct endocrine cell type in the gastrointestinal tracts of rats and humans. Endocrinology 2000;141:4255-61.
24. Lee SW, Park MC, Park YB, et al. Measurement of the serum leptin level could assist disease activity monitoring in rheumatoid arthritis. Rheumatol Int 2007;27:537-40.
25. Rindi G, Savio A, Torsello A, et al. Ghrelin expression in gut endocrine growths. Histochem Cell Biol 2002;117:521-5. (Pubitemid 34666955)
26. Jeffery PL, McGuckin MA, Linden SK. Endocrine impact of Helicobacter pylori: focus on ghrelin and ghrelin o-acyltransferase. World J Gastroenterol 2011;17:1249-60.
27. Islami F, Kamangar F. Helicobacter pylori and esophageal cancer risk: a meta-analysis. Cancer Prev Res 2008;1:329-38.
28. Baatar D, Patel K, Taub DD. The effects of ghrelin on inflammation and the immune system. Mol Cell Endocrinol 2011; 340:44-58.
29. Kawashima J, Ohno S, Sakurada T, et al. Circulating acylated ghrelin level decreases in accordance with the extent of atrophic gastritis. J Gastroenterol 2009;44:1046-54.
30. Gonzalez-Rey E, Chorny A, Delgado M. Therapeutic action of ghrelin in a mouse model of colitis. Gastroenterology 2006;130:1707-20. (Pubitemid 43668852)
31. Dixit VD, Taub DD. Ghrelin and immunity: a young player in an old field. Exp Gerontol 2005;40:900-10. (Pubitemid 41540440)
32. Hattori N. Expression, regulation and biological actions of growth hormone (GH) and ghrelin in the immune system. Growth Horm IGF Res 2009; 19:187-97.
33. Taub DD. Novel connections between the neuroendocrine and immune systems: the ghrelin immunoregulatory network. Vitam Horm 2008;77:325-46.
34. Chopin L, Walpole C, Seim I, et al. Ghrelin and cancer. Mol Cell Endocrinol 2011;340:65-9.
35. Waseem T, Javaid Ur R, Ahmad F, et al. Role of ghrelin axis in colorectal cancer: a novel association. Peptides 2008;29:1369-76.
36. Nikolopoulos D, Theocharis S, Kouraklis G. Ghrelin's role on gastrointestinal tract cancer. Surg Oncol 2010;19:e2-10.
37. Cassoni P, Ghe C, Marrocco T, et al. Expression of ghrelin and biological activity of specific receptors for ghrelin and des-acyl ghrelin in human prostate neoplasms and related cell lines. Eur J Endocrinol 2004;150:173-84. (Pubitemid 38312810)
38. Jeffery PL, Herington AC, Chopin LK. Expression and action of the growth hormone releasing peptide ghrelin and its receptor in prostate cancer cell lines. J Endocrinol 2002;172:R7-11.
39. Yeh AH, Jeffery PL, Duncan RP, et al. Ghrelin and a novel preproghrelin isoform are highly expressed in prostate cancer and ghrelin activates mitogen-activated protein kinase in prostate cancer. Clin Cancer Res 2005;11:8295-303. (Pubitemid 41746940)